- Report
- January 2025
- 75 Pages
Australia
From €744EUR$780USD£624GBP
- Report
- January 2025
- 68 Pages
New Zealand
From €744EUR$780USD£624GBP
- Book
- May 2025
- 176 Pages
- Book
- May 2015
- 144 Pages
The General Practice market is a segment of the pharmaceutical industry that focuses on the development and distribution of therapeutic products for the treatment of common medical conditions. These products are typically prescribed by general practitioners and other primary care providers, and are used to treat a wide range of conditions, including allergies, asthma, diabetes, hypertension, and depression.
The General Practice market is highly competitive, with a number of large pharmaceutical companies vying for market share. Companies in the market include Pfizer, GlaxoSmithKline, Merck, Novartis, Sanofi, and Bayer. These companies are engaged in research and development of new therapeutic products, as well as marketing and distribution of existing products. Additionally, many of these companies have established partnerships with other healthcare providers, such as hospitals and clinics, to expand their reach and increase their market share. Show Less Read more